By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Phoenix RelationsPhoenix RelationsPhoenix Relations
  • Home
  • Categories
    • CrimeUnlimited
    • Economy
    • Education
    • Entertainment
    • HealthHot
    • Exclusives
    • News100+
    • Politics
    • Press Realeases
    • Sports
    • Tech
    • Opinions
  • About
  • Privacy Policy
  • Contact Us
Reading: Japan Approves Alzheimer’s Blood Test Kit
Share
Sign In
Notification Show More
Font ResizerAa
Phoenix RelationsPhoenix Relations
Font ResizerAa
Search
  • Home
  • About Us
  • Blog
  • Categories
    • Crime
    • Economy
    • Education
    • Entertainment
    • Health
    • Exclusives
    • News
    • Politics
    • Press Realeases
    • Sports
    • Tech
    • Opinions
  • Contact
  • Privacy Policy
Have an existing account? Sign In
Follow US
  • Advertise
© 2024 Phoenix Relations. All Rights Reserved.
Health

Japan Approves Alzheimer’s Blood Test Kit

Phoenix Relations
Last updated: 24 December 2022 11:00
Phoenix Relations
Share
2 Min Read
SHARE

Japan has approved a blood test kit to diagnose Alzheimer’s disease, its manufacturer announced on Thursday, a rare advance in tackling a condition that affects tens of millions worldwide.

 


Sysmex Corporation said it was now working to get the kit, which measures the accumulation of a protein that is a marker for the disease, to market “as soon as possible”.

 

 

Existing methods of diagnosing Alzheimer’s are expensive and medically intrusive, often involving a brain scan or spinal tap.

 

 

“Sysmex has been developing a technology to more quickly and readily identify the accumulation of (amyloid beta) in the brain in order to solve issues in the diagnosis of Alzheimer’s disease,” the company said.

 

 

“Unlike conventional testing methods… (the kit) allows testing with blood, thus reducing the physical, emotional, and financial burden on patients,” it added.

 

 

The Alzheimer’s Association, a US-based group, says “an urgent need exists for simple, inexpensive, non-invasive and easily available diagnostic tools such as blood tests to diagnose the disease”.

 

 

“In the future, they are very likely to revolutionise the diagnostic process for Alzheimer’s and all other dementia,” the group says on its website.

 

 

Last month, data showed a new drug called lecanemab slowed cognitive decline in Alzheimer’s patients by 27 percent across an 18-month period.

 

 

The data also revealed adverse effects including brain bleeds and swelling, but was largely hailed as offering a “real treatment option” for those with the degenerative cognitive disease.

 

 

In Alzheimer’s disease, two key proteins, tau and amyloid beta, build up into tangles and plaques, known together as aggregates, which cause brain cells to die and lead to brain shrinkage.

You Might Also Like

President Macron: Hantavirus Situation in France is Now ‘Under Control’

WHO Confirms Malaria Vaccine Success in Ghana, Kenya, and Malawi

WHO Issues Hantavirus Health Advisory as Death Toll Rises to Three

CNN Founder Ted Turner Dies at 87: Legacy of a Media Icon

Australian State Bans Testing Of Illicit Drugs

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.

By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Copy Link Print
Share
Previous Article Osun State Govt Asks Oyetola, Others To Return Vehicles Worth N2.9bn
Next Article IGP Deploys Frank Mba, Six Other Police Commissioners
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

//

We influence 20 million users and we are the number one  news network on the planet

Stay Connected

235.3kFollowersLike
69.1kFollowersFollow
11.6kFollowersPin
56.4kFollowersFollow
136kSubscribersSubscribe
4.4kFollowersFollow
- Advertisement -
Ad imageAd image

Latest News

Nvidia’s board is reportedly ‘not considering’ hiring Jensen
Default Blog 17 November 2026
EU Sanctions Pro-Russian Hacker Group and Propaganda Firm
Press Releases 17 November 2026
Lawyer on the microchip case passcode
Press Releases 17 November 2026
Power Minister Tegbe Reaffirms Tinubu Administration’s Commitment to Improved Electricity Supply
Press Releases 16 November 2026

Technology

  • Advertise with us
  • Terms & Conditions
  • Privacy Policy

Health

  • Advertise

Entertainment

Sign Up for Our Weeky Newsletter

Subscribe to our weekly newsletter to get our newest article/news/articles instantly!

Phoenix RelationsPhoenix Relations
Follow US
© 2024 Phoenix Relations. | All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?